{"entity":{"type":"insider","cik":"0001413306","url":"/insider/0001413306","json_url":"/insider/0001413306.json","name":"Grais Linda","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":11,"first":"2007-11-19","last":"2026-08-12","span_basis":"filed_date"},"name_variants":[{"name":"Grais Linda","source":"filing","n_filings":2,"first_seen":"2023-05-16","last_seen":"2026-08-12"},{"name":"Grais Linda S","source":"filing","n_filings":9,"first_seen":"2007-11-19","last_seen":"2016-12-08"}],"transactions":[{"id":9293645,"accession":"0001628280-26-056304","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-056304","line_url":"/filing/0001628280-26-056304","is_derivative":false,"issuer_cik":"0001060955","issuer_name":"ICON PLC","issuer_ticker":"ICLR","issuer_name_source":null,"issuer_url":"/issuer/0001060955","owner_cik":"0001413306","owner_name":"Grais Linda","owner_display_name":"Grais Linda","owner_url":"/insider/0001413306","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":841.0,"shares_display":"841","price_per_share":164.2910820451843,"price_display":"164.29","price_state":"stated","total_value":138168.8,"total_display":"138,168.80","total_whole":"138,169","shares_owned_after":6229.0,"shares_owned_after_display":"6,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-11","filed_date":"2026-08-12","scope":"insider","n_lines":4},{"id":7818575,"accession":"0001610717-23-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-23-000041","line_url":"/filing/0001610717-23-000041#line-1","is_derivative":false,"issuer_cik":"0001413306","issuer_name":"Corvus Pharmaceuticals, Inc.","issuer_ticker":"CRVS","issuer_name_source":null,"issuer_url":"/issuer/0001413306","owner_cik":"0001413306","owner_name":"Grais Linda","owner_display_name":"Grais Linda","owner_url":"/insider/0001413306","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.45,"price_display":"2.45","price_state":"stated","total_value":24500.0,"total_display":"24,500.00","total_whole":"24,500","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-16","scope":"insider"},{"id":2974490,"accession":"0001274644-16-000154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001274644-16-000154","line_url":"/filing/0001274644-16-000154#line-1","is_derivative":false,"issuer_cik":"0001274644","issuer_name":"Ocera Therapeutics, Inc.","issuer_ticker":"OCRX","issuer_name_source":null,"issuer_url":"/issuer/0001274644","owner_cik":"0001413306","owner_name":"Grais Linda S","owner_display_name":"Grais Linda S","owner_url":"/insider/0001413306","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":2.14,"price_display":"2.14","price_state":"stated","total_value":14980.0,"total_display":"14,980.00","total_whole":"14,980","shares_owned_after":70000.0,"shares_owned_after_display":"70,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-07","filed_date":"2016-12-08","scope":"insider"},{"id":2185191,"accession":"0001274644-16-000101","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001274644-16-000101","line_url":"/filing/0001274644-16-000101#line-1","is_derivative":false,"issuer_cik":"0001274644","issuer_name":"Ocera Therapeutics, Inc.","issuer_ticker":"OCRX","issuer_name_source":null,"issuer_url":"/issuer/0001274644","owner_cik":"0001413306","owner_name":"Grais Linda S","owner_display_name":"Grais Linda S","owner_url":"/insider/0001413306","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.19,"price_display":"3.19","price_state":"stated","total_value":9570.0,"total_display":"9,570.00","total_whole":"9,570","shares_owned_after":63000.0,"shares_owned_after_display":"63,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-04","filed_date":"2016-03-07","scope":"insider"},{"id":3094979,"accession":"0001274644-16-000096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001274644-16-000096","line_url":"/filing/0001274644-16-000096#line-1","is_derivative":false,"issuer_cik":"0001274644","issuer_name":"Ocera Therapeutics, Inc.","issuer_ticker":"OCRX","issuer_name_source":null,"issuer_url":"/issuer/0001274644","owner_cik":"0001413306","owner_name":"Grais Linda S","owner_display_name":"Grais Linda S","owner_url":"/insider/0001413306","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.38,"price_display":"2.38","price_state":"stated","total_value":23800.0,"total_display":"23,800.00","total_whole":"23,800","shares_owned_after":60000.0,"shares_owned_after_display":"60,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-22","filed_date":"2016-01-25","scope":"insider"},{"id":2336484,"accession":"0001274644-16-000094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001274644-16-000094","line_url":"/filing/0001274644-16-000094#line-1","is_derivative":false,"issuer_cik":"0001274644","issuer_name":"Ocera Therapeutics, Inc.","issuer_ticker":"OCRX","issuer_name_source":null,"issuer_url":"/issuer/0001274644","owner_cik":"0001413306","owner_name":"Grais Linda S","owner_display_name":"Grais Linda S","owner_url":"/insider/0001413306","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.08,"price_display":"2.08","price_state":"stated","total_value":20800.0,"total_display":"20,800.00","total_whole":"20,800","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-15","filed_date":"2016-01-19","scope":"insider"},{"id":8153063,"accession":"0001274644-15-000034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001274644-15-000034","line_url":"/filing/0001274644-15-000034#line-1","is_derivative":false,"issuer_cik":"0001274644","issuer_name":"Ocera Therapeutics, Inc.","issuer_ticker":"OCRX","issuer_name_source":null,"issuer_url":"/issuer/0001274644","owner_cik":"0001413306","owner_name":"Grais Linda S","owner_display_name":"Grais Linda S","owner_url":"/insider/0001413306","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":3.73,"price_display":"3.73","price_state":"stated","total_value":111900.0,"total_display":"111,900.00","total_whole":"111,900","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-06","filed_date":"2015-05-06","scope":"insider"},{"id":6276953,"accession":"0001104659-14-051611","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-14-051611","line_url":"/filing/0001104659-14-051611#line-1","is_derivative":false,"issuer_cik":"0001274644","issuer_name":"Ocera Therapeutics, Inc.","issuer_ticker":"OCRX","issuer_name_source":null,"issuer_url":"/issuer/0001274644","owner_cik":"0001413306","owner_name":"Grais Linda S","owner_display_name":"Grais Linda S","owner_url":"/insider/0001413306","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.928,"price_display":"5.93","price_state":"stated","total_value":59280.0,"total_display":"59,280.00","total_whole":"59,280","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-11","filed_date":"2014-07-15","scope":"insider"},{"id":7567835,"accession":"0001181431-10-041125","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-10-041125","line_url":"/filing/0001181431-10-041125#line-3","is_derivative":false,"issuer_cik":"0001276600","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001276600","owner_cik":null,"owner_name":"InterWest Partners IX, LP; Grais Linda S; Pepper Douglas A; Ehrlich Christopher B; NASR KHALED","owner_display_name":"InterWest Partners IX, LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1227333.0,"shares_display":"1,227,333","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":6136665.0,"total_display":"6,136,665.00","total_whole":"6,136,665","shares_owned_after":3548643.0,"shares_owned_after_display":"3,548,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-06","filed_date":"2010-08-10","scope":"insider"},{"id":7249660,"accession":"0001413306-10-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001413306-10-000001","line_url":"/filing/0001413306-10-000001","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001413306","owner_name":"Grais Linda S","owner_display_name":"Grais Linda S","owner_url":"/insider/0001413306","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":210809.0,"shares_display":"210,809","price_per_share":7.376125782106077,"price_display":"7.38","price_state":"stated","total_value":1554953.7,"total_display":"1,554,953.70","total_whole":"1,554,954","shares_owned_after":491889.0,"shares_owned_after_display":"491,889","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-03-29","filed_date":"2010-03-30","scope":"insider","n_lines":2},{"id":7085755,"accession":"0001209191-07-065052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-065052","line_url":"/filing/0001209191-07-065052#line-1","is_derivative":false,"issuer_cik":"0001276600","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001276600","owner_cik":null,"owner_name":"Grais Linda S; Westerlind Victor A; Nash H Ronald; InterWest Management Partners IX, LLC; Pepper Douglas A; Ehrlich Christopher B; NASR KHALED; Kjellson Nina S","owner_display_name":"Grais Linda S","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","total_whole":"1,500,000","shares_owned_after":187500.0,"shares_owned_after_display":"187,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-11-15","filed_date":"2007-11-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001060955","name":"ICON PLC","url":"/issuer/0001060955","role":"Director","n_filings":1,"first_seen":"2026-08-12","last_seen":"2026-08-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001626971","name":"Corvus Pharmaceuticals, Inc.","url":"/issuer/0001626971","role":"Director","n_filings":1,"first_seen":"2023-05-16","last_seen":"2023-05-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001274644","name":"Ocera Therapeutics, Inc.","url":"/issuer/0001274644","role":"Director, Officer (President and CEO)","n_filings":6,"first_seen":"2014-07-15","last_seen":"2016-12-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001356857","name":"Trius Therapeutics Inc","url":"/issuer/0001356857","role":"Other","n_filings":1,"first_seen":"2010-08-10","last_seen":"2010-08-10"},{"type":"issuer","type_label":"ISSUER","cik":"0000907654","name":"ARCA biopharma, Inc.","url":"/issuer/0000907654","role":"Director","n_filings":1,"first_seen":"2010-03-30","last_seen":"2010-03-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001371217","name":"EnteroMedics Inc","url":"/issuer/0001371217","role":"Ten percent owner","n_filings":1,"first_seen":"2007-11-19","last_seen":"2007-11-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001413306","retrieved_at":"2026-08-22T20:39:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}